Juillerat-Jeanneret, L.

receptor 2 receptors pd 123319 ang ii angiotensin irbesartan study heart vasodilation effect artery –mediated response presence binding figure br j pharmacol ang ii crc antagonist increase tissue radioligand binding studies b 2 receptors 2 receptor mrna circulation contraction experiment donor control pharmacol angiotensin ii microarterie concentration rt-pcr 2 receptor blockade –induced result radioligand i-ang relaxation membrane minute circ res segment vasoconstriction condition contractile carcinoma membrane fractions protein inhibitor catherine chapuis bernasconi contractile response fraction j clin 2 receptor expression expression 2 receptor antagonist 10 nmol /l 2 receptor ic 50 500 ␮ m 1 receptor antagonists vries r concentration-dependent manner l-name 125 i-ang ii pd 123319. ii type 2 0.3 mmol /l j pharmacol exp blockade 1 receptors absence porcine pd 123319-induced potentiation breast carcinoma cells hypertension stimulation preconstriction